GOP Senator Claims Marijuana Is A ‘Gateway Drug,’ Voicing Opposition To Trump’s Rescheduling Order
DEA Boosts Legal Production Levels For Psychedelics Like Psilocybin And DMT In Final Rule For 2026
Marijuana Industry Political Committee Gave Another $1.05 Million To Trump’s Super PAC Ahead Of Rescheduling Order, FEC Filings Show
Massachusetts Bill To Double Marijuana Possession Limit And Revise Regulatory Framework Heads To Conference Committee
U.S. Supreme Court Schedules Hearing In Case On Marijuana Consumers’ Gun Rights
Marijuana Users Are Being Unjustly Jailed For Allegedly Driving Under The Influence, Government-Funded Study Shows
California Officials Award $30 Million In Marijuana Revenue To Support Research On THC Drinks, Terpenes And Tribal Cannabis Sales
Medical Marijuana Use Is ‘Prevalent’ Among People With Disabilities—And It Helps Treat Pain, New Federally Funded Study Shows
Teen Marijuana Use ‘Remained Stable’ As Legalization Expands, Federal Health Officials Acknowledge
CBD Provides Pain Relief, Improves Sleep And Aids Relaxation, Study Involving Olympic Athletes Shows
State Marijuana Regulators Share Tips On How To Stay Safe And Legal Around The Holidays
One In Three Americans ‘Pre-Game’ With Marijuana Before Family Holiday Gatherings, Survey Finds
As More Americans Choose Marijuana Over Alcohol, Mainstream Media Notices The ‘Cousin Walk’ Thanksgiving Tradition
Joe Rogan Slams ‘Really Bad’ Federal Hemp Ban Trump Signed, Blaming Alcohol Industry For Influencing Congress
New Netflix Documentary Shows How Psychedelics Help Military Veterans Heal Trauma
Marijuana Consumers Are More Likely To Shop At Target Following Decision To Sell Cannabis-Infused Drinks, Poll Shows
Marijuana Company Sues DoorDash, Total Wine And Others Over Alleged Illegal Sales Of Hemp THC Products
Whiskey Company Scales Back Operations, Citing ‘Consumer Shifts’ Toward Marijuana As Alcohol Alternative
Target Begins Selling THC-Infused Cannabis Drinks As Congress Debates Possible Hemp Law Reversal
No, Carrier Pigeons Will Not Be Delivering Marijuana In New York, Retailer Confirms After Marketing Stunt Fools Media Outlets
Supreme Court schedules cannabis case argument (Newsletter: January 5, 2026)
Congressional dispute over Biden’s cannabis pardons (Newsletter: January 2, 2026)
Pennsylvania should legalize cannabis, top lawmaker says (Newsletter: January 1, 2026)
Ohio petition could put cannabis back on the ballot (Newsletter: December 31, 2025)
Could DOJ ignore Trump’s cannabis rescheduling order? (Newsletter: December 30, 2025)
Published
on
By
A GOP senator says his opposition to marijuana reform—and his conviction that cannabis is a “gateway drug”—hasn’t changed even after President Donald Trump signed a rescheduling order.
Asked about the president’s directive to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA), Sen. Rick Scott (R-FL) told Marijuana Moment that cannabis is a “gateway drug” and that his position is informed by the fact that his brother died from a drug overdose.
Scott said he does “understand medicinal marijuana,” which voters in his state legalized via a constitutional amendment at the ballot in 2016.
The senator, who previously served as Florida’s governor, also noted that a separate initiative to legalize recreational cannabis on the 2024 ballot failed to reached the 60 percent threshold needed to be enacted—though it did get majority support.
Pressed on Trump’s assertion that rescheduling cannabis would free up research and whether he’d support the policy change in that respect, Scott said simply: “Why don’t we just do the research?”
Scott was among a group of GOP lawmakers who sent a letter last month challenging the marijuana rescheduling push, urging the Trump administration to trash the policy proposal.
Ahead of a vote on a Florida ballot initiative to legalize marijuana for adult use—which gained majority support but not enough to reach a 60 percent threshold—the senator pledged to do everything he could to defeat it.
The campaign behind that initiative has mounted another push for the ballot, but activists have faced complications amid litigation and invalidated signatures from the state.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
As far as federal rescheduling is concerned, a bipartisan majority of American voters across nearly all major demographics—age, race, gender and political affiliation—support legalizing marijuana, according to a new poll released just days after Trump issued the executive order.
The latest poll from the Daily Mail is generally consistent with the growing bipartisanship around marijuana legalization, but another recent survey from YouGov showed Republicans evenly divided on the issue, with 41 percent in favor and 41 percent against the broader reform.
The rescheduling process initiated by the Biden administration, which Trump has now asked to be finalized, is still pending. Congressional researchers also recently released a report noting that there’s a chance the Justice Department could opt to start the process all over again, or even not complete it at all. But as prior polling has indicated, it’s a politically popular reform across the aisle.
The president said last month that cannabis can “make people feel much better” and serve as a “substitute for addictive and potentially lethal opioid painkillers.” He clarified, however, that he personally has no interest in using marijuana himself.
Trump also dismissed the concerns of GOP lawmakers who oppose rescheduling, pointing out that an overwhelming majority of Americans support the reform and that cannabis can help people—including his personal friends—who are suffering from serious health issues.
The LCB contributed reporting from Washington, D.C.
Kyle Jaeger is Marijuana Moment’s Sacramento-based managing editor. He’s covered drug policy for more than a decade—specializing in state and federal marijuana and psychedelics issues at publications that also include High Times, VICE and attn. In 2022, Jaeger was named Benzinga’s Cannabis Policy Reporter of the Year.
Add Marijuana Moment as a preferred source on Google.
All the cannabis news you need, all in one place. Copyright © 2017-2025 Marijuana Moment LLC ® and Tom Angell
